1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Treatment of Refractory Tumor Necrosis Factor Inhibitor–Induced Palmoplantar … – Archives of Dermatology

October 17, 2011Immunosuppressive Drugsadmin

Treatment of Refractory Tumor Necrosis Factor Inhibitor–Induced Palmoplantar ...
Archives of Dermatology
Initial treatment involved cessation of adalimumab and the addition of topical corticosteroids. This was ineffective, and she was quickly started on a regimen of cyclosporine, 5 mg/kg/d, which drastically cleared her PPP within 2 weeks. ...

Post navigation

← Biomarker-guided heart failure treatment significantly reduces complications – EurekAlert (press release) Big Pharma's 10 Biggest Dividend Yields To Buy Now (Part 1) – Seeking Alpha →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos